"Slimming Pen" is out of stock? Are diabetics running out of medicine? Clarification: Wrong message! There is more than one type of slim pen, each one has its own type

With the refinement of diet and excessive intake of high-fat and high-sugar foods, the number of people suffering from diabetes and obesity in the world is on the rise. In recent years, the "Slim Pen" that has become popular all over the world is regarded as one of the best weapons for weight loss because its main ingredient is incretin, which can suppress appetite and control weight. Recently, it was reported that due to the demand for weight loss, there was a serious shortage of products, making it impossible for diabetic patients in need to buy them. In response to this, Dr. Cai Fengzhou, chairman of the Taiwan Aesthetic Medicine Industry National Association, clarified that "this is wrong information, because the indications of these drugs are completely different and will not affect any rights of diabetic patients."

There is more than one type of “slimming pen”? The drug indications are fundamentally different and will not affect the rights and interests of diabetic patients.

The four common incretin injections on the market include Sanofi, Panadol, Panadol, and E-Care. The government has different indications for different drugs. Manufacturers sell drugs to different medical institutions and patients based on different indications. Chairman Tsai Feng-chou further emphasized: "The indications for drugs for weight loss patients and diabetic patients approved by the government are completely different, so they should be treated separately." "Don't blame other reasons for the global manufacturing shortage problem. Taiwan media and public opinion should not become experts in randomly raising issues, and should discuss the matter rationally!"

Currently, the only incretin approved for weight control in China is "SanFiber", which is also the injection used in most medical beauty clinics or weight loss clinics. What is out of stock is "EasyTone and Yitosan" that diabetic patients need to use every week. Simply put, the main ingredients of the above four incretin injections (Sanfibrate, Panadol, Panadol, and E-Choice) are GLP-1, which can suppress appetite and increase satiety, and they all require a doctor's diagnosis and prescription to obtain. However, currently, only SanofiZan is the only incretin injection legally used in Taiwan for weight control and weight loss. The instructions for Panadol, Panadol and E-Chow only have the indication of "blood sugar control in patients with type 2 diabetes". Even if they have the effect of weight loss, they should not and will not be used directly as weight loss drugs.

▲Comparison table of common enterocin injections (Table provided by: Taiwan Aesthetic Medicine Industry National Association)

Comparison table of common enterocrine injections (Table provided by: Taiwan Aesthetic Medicine Industry National Association)

The slimming pen that was reported to be out of stock recently is actually "EasyTec" and "IcetoZan" which are injected once a week and are indicated for the control of type 2 diabetes. They are different from "Sanxianda" which is used daily by weight loss patients. Chairman Cai Fengzhou also called on: "People who want to lose weight should not only choose drugs and places that meet the indications for weight loss, but also collect information from multiple sources and think carefully, and undergo detailed consultation and evaluation by doctors. At the same time, do not rely too much on drugs, develop good living habits, and combine diet control and regular exercise to maintain a long-term and healthy body shape!"